Literature DB >> 437372

The effect of age on insulin-degrading activity in rat tissue.

K Runyan, W C Duckworth, A E Kitabchi, G Huff.   

Abstract

Insulin-degrading activity was measured in the 100,000g supernatant fraction of muscle, liver, and kidney from rats of varying ages. Young animals (four weeks old) had the highest activity in all three tissues. By seven weeks of age the activity in both muscle and liver had decreased significantly as compared with four-week-old animals. A slight but nonsignificant decrease occurred in kidney. In animals over one year of age the insulin-degrading activity in all three tissues was significantly less than the activities at either four or seven weeks. In contrast the effect of age on degradation of albumin and parathormone was much less marked.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 437372     DOI: 10.2337/diab.28.4.324

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  10 in total

1.  Degradation of soluble amyloid beta-peptides 1-40, 1-42, and the Dutch variant 1-40Q by insulin degrading enzyme from Alzheimer disease and control brains.

Authors:  A Pérez; L Morelli; J C Cresto; E M Castaño
Journal:  Neurochem Res       Date:  2000-02       Impact factor: 3.996

2.  Insulin degrading enzyme activity and insulin binding of erythrocytes in normal subjects and Type 2 (non-insulin-dependent) diabetic patients.

Authors:  E Standl; H J Kolb
Journal:  Diabetologia       Date:  1984-07       Impact factor: 10.122

Review 3.  Targeting Insulin-Degrading Enzyme in Insulin Clearance.

Authors:  Malcolm A Leissring; Carlos M González-Casimiro; Beatriz Merino; Caitlin N Suire; Germán Perdomo
Journal:  Int J Mol Sci       Date:  2021-02-24       Impact factor: 5.923

4.  HHEX_23 AA Genotype Exacerbates Effect of Diabetes on Dementia and Alzheimer Disease: A Population-Based Longitudinal Study.

Authors:  Wei-Li Xu; Nancy L Pedersen; Lina Keller; Grégoria Kalpouzos; Hui-Xin Wang; Caroline Graff; Bengt Winblad; Lars Bäckman; Laura Fratiglioni
Journal:  PLoS Med       Date:  2015-07-14       Impact factor: 11.069

Review 5.  Diabetes and Alzheimer disease, two overlapping pathologies with the same background: oxidative stress.

Authors:  Sergio Rosales-Corral; Dun-Xian Tan; Lucien Manchester; Russel J Reiter
Journal:  Oxid Med Cell Longev       Date:  2015-02-26       Impact factor: 6.543

6.  Insulin signaling in Drosophila melanogaster mediates Aβ toxicity.

Authors:  Yunpeng Huang; Zhihui Wan; Zhiqing Wang; Bing Zhou
Journal:  Commun Biol       Date:  2019-01-08

Review 7.  Modulation of Insulin Sensitivity by Insulin-Degrading Enzyme.

Authors:  Carlos M González-Casimiro; Beatriz Merino; Elena Casanueva-Álvarez; Tamara Postigo-Casado; Patricia Cámara-Torres; Cristina M Fernández-Díaz; Malcolm A Leissring; Irene Cózar-Castellano; Germán Perdomo
Journal:  Biomedicines       Date:  2021-01-17

8.  The type 2 diabetes-associated gene ide is required for insulin secretion and suppression of α-synuclein levels in β-cells.

Authors:  Pär Steneberg; Lisandro Bernardo; Sara Edfalk; Lisa Lundberg; Fredrik Backlund; Claes-Göran Ostenson; Helena Edlund
Journal:  Diabetes       Date:  2013-01-24       Impact factor: 9.461

9.  Receptor-linked degradation of 125I-insulin is mediated by internalization in isolated rat hepatocytes.

Authors:  P Gorden; P Freychet; J L Carpentier; B Canivet; L Orci
Journal:  Yale J Biol Med       Date:  1982 Mar-Apr

10.  Insulin-degrading enzyme prevents α-synuclein fibril formation in a nonproteolytical manner.

Authors:  Sandeep K Sharma; Erik Chorell; Pär Steneberg; Emma Vernersson-Lindahl; Helena Edlund; Pernilla Wittung-Stafshede
Journal:  Sci Rep       Date:  2015-07-31       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.